Clinical course of novel COVID-19 infection in pregnant women.
Roman G ShmakovAndrey PrikhodkoEvgeniya PolushkinaElena ShmakovaAleksey PyregovVladimir BychenkoTatyana V PriputnevichGrigory O DolgushinEkaterina L YarotskayaOleg PekarevNikolai BolibokDmitriy DegtyarevGennady T SukhikhPublished in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2020)
Mostly, the manifestations of COVID-19 were mild. However, 9% of cases were severe, and could contribute to preterm delivery or maternal morbidity. Main predictors of severe COVID-19 course in pregnant women were a decrease in the levels of erythrocytes and lymphocytes and increase in the levels of alanine aminotransferase and CRP. Elimination of the virus in pregnant women required more time due to altered immunity. No evidence of vertical transmission during pregnancy and delivery was found. However, the possibility of this cannot be excluded.